Literature DB >> 3895024

Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 152 hydrocephalic patients.

K Schmidt, F Gjerris, O Osgaard, E F Hvidberg, J E Kristiansen, B Dahlerup, C Kruse-Larsen.   

Abstract

The authors report a prospective, randomized 18-month study on the effect of prophylactic antibiotic treatment in 152 hydrocephalic patients in whom clean shunt operations or revisions were done. The treated group received methicillin (totally 200 mg/kg) divided into six i.v. doses during 24 hours starting at the induction of anesthesia. Patients allergic to penicillin received erythromycin instead. Seventy-nine patients received antibiotics, and 73 (the control group) received none. All patients were followed at least 6 months after operation or to their death. Eleven patients developed signs of infection, giving an overall infection rate of 7.2%; however, the infection occurred less than 1 month after the operation in only half of these. Six of the patients had septicemia, 4 had peritonitis, and 1 had meningitis. In the treated group, the infection rate was 8.9%; in the control group, the rate was 5.5%. There was no statistically significant difference. The prophylactic antibiotic regimen in this investigation did not reduce the infection rate connected with cerebrospinal fluid shunting procedures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3895024     DOI: 10.1227/00006123-198507000-00001

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  11 in total

1.  Prophylactic antibiotics in pediatric shunt surgery.

Authors:  N Biyani; G Grisaru-Soen; P Steinbok; S Sgouros; S Constantini
Journal:  Childs Nerv Syst       Date:  2006-05-18       Impact factor: 1.475

2.  Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 129 patients.

Authors:  J Zentner; J Gilsbach; T Felder
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

3.  Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts.

Authors:  B M Borgbjerg; F Gjerris; M J Albeck; S E Børgesen
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection.

Authors:  Sebastian Hhmj Arts; Hieronymus Damianus Boogaarts; Erik J van Lindert
Journal:  Cochrane Database Syst Rev       Date:  2019-06-04

5.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

6.  Antibiotic single-dose prophylaxis of shunt infections.

Authors:  J Blum; M Schwarz; D Voth
Journal:  Neurosurg Rev       Date:  1989       Impact factor: 3.042

7.  Cerebrospinal fluid shunt infections in children. A study on the relationship between the etiology of hydrocephalus, age at the time of shunt placement, and infection rate.

Authors:  M Ammirati; A J Raimondi
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

8.  Distribution of bacteria in the operating room environment and its relation to ventricular shunt infections: a prospective study.

Authors:  A C Duhaime; K Bonner; K L McGowan; L Schut; L N Sutton; S Plotkin
Journal:  Childs Nerv Syst       Date:  1991-08       Impact factor: 1.475

9.  Zero tolerance to shunt infections: can it be achieved?

Authors:  M S Choksey; I A Malik
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

10.  A randomized controlled trial of perioperative rifampin/trimethoprim in cerebrospinal fluid shunt surgery.

Authors:  B C Walters; L Goumnerova; H J Hoffman; E B Hendrick; R P Humphreys; C Levinton
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.